Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

Completed · Early Phase 1

Conditions studied: Drug Safety

In brief

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

Key facts

Study ID

NCT01722916

Run by

Northwestern University

People needed

5

Starts

2012-10-01

Expected to finish

2022-02-22

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 and over
• The subjects are in good health
• The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator

You may not qualify if…

• Under 18 years of age
• Pregnancy or Lactation
• Subjects who are unable to understand the protocol or to give informed consent
• Subjects with mental illness
• Recent Accutane use in the past 6 months
• Subjects prone to hypertrophic and keloidal scarring
• Subjects with tattoos and/or scars on upper medial arms (the treatment area)
• Subjects with known hypersensitivity to hyaluronic acid

Where it is running

• Northwestern University Department of Dermatology — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.